Moderna | MRNA - Equity Capital And Reserves



Moderna reported $9.4B in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
Acadia Pharmaceuticals USD 822.38M 57.14M Jun/2025
Adcock Ingram Holdings ZAR 5.54B 131.19M Dec/2024
Agios Pharmaceuticals USD 1.37B 96.97M Jun/2025
Alnylam Pharmaceuticals USD 250.59M 135.16M Jun/2025
Amgen USD 7.43B 1.22B Jun/2025
Arrowhead Research USD 522.31M 161.91M Jun/2025
Biogen USD 17.63B 655.3M Jun/2025
BioMarin Pharmaceutical USD 6.03B 233.65M Jun/2025
Celltrion KRW 17.14T 298.25B Mar/2025
Cspc Pharmaceutical CNY 32.26B 2.59B Dec/2024
Dianthus Therapeutics USD 303.08M 49.4M Jun/2025
Divis Laboratories Ltd 149.69B 12.52B Mar/2025
Gilead Sciences USD 19.67B 596M Jun/2025
GlaxoSmithKline GBP 14.35B 197M Jun/2025
Incyte USD 4.17B 503.34M Jun/2025
Ionis Pharmaceuticals USD 631.72M 156M Jun/2025
Kangmei Pharma CNY 7.73B 546.26M Jun/2025
Knight Therapeutics CAD 773.91M 11.11M Sep/2024
Laboratorios Farma EUR 574.72M 6.82M Jun/2025
Malin Corporation EUR 193.2M 75M Dec/2024
Moderna USD 9.4B 667M Jun/2025
Organigram Holdings CAD 385.5M 61.85M Jun/2025
Pharma Mar EUR 201.53M 4.06M Jun/2025
Qiagen NV USD 3.51B 97.61M Jun/2025
Regeneron Pharmaceuticals USD 29.94B 551.3M Jun/2025
Sarepta Therapeutics USD 1.36B 214.66M Jun/2025
Sartorius EUR 2.66B 51.3M Jun/2025
Sino Biopharmaceutical CNY 31.96B 884.2M Dec/2024
Tilray USD 3.47B 5.16M Nov/2024
Ultragenyx Pharmaceutical USD 151.29M 7.04M Jun/2025
United Therapeutics USD 7.17B 366.4M Jun/2025
Vertex Pharmaceuticals USD 17.18B 679.1M Jun/2025
Zz Pientze Pharmaceu 14.65B 617.48M Jun/2025